Minerva Neurosciences | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Acadia Pharmaceuticals USD 16K 0 2024-12
Adma Biologics USD 24K 0 2024-12
ALKERMES USD 1.8M 35K 2025-03
AstraZeneca USD 388M 0 2025-03
Bristol-Myers Squibb USD 292M 0 2025-03
Cipla INR 1.62B 400K 2024-09
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 248K 0 2024-12
CSL USD 557M 20M 2024-06
Dynavax Technologies USD 124K 1000 2025-03
Eli Lilly USD 592.6M 200K 2025-03
GlaxoSmithKline GBP 1.35B 1000K 2025-03
Grifols EUR 119.6M 0 2024-12
Halozyme Therapeutics USD 123K 0 2025-03
Ionis Pharmaceuticals USD 159K 1000 2025-03
J&J USD 3.12B 0 2025-03
Merck USD 1.79B 0 2025-03
Neurocrine Biosciences USD 100K 0 2024-12
Novartis USD 793M 0 2024-12
Pfizer USD 481M 1000K 2025-03
Roche Holding CHF 107M 0 2024-06
Takeda JPY 1.69T 0 2024-12



Minerva Neurosciences Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.